Dr Weiguang Zeng
Senior Research Officer NH&MRC
Department of Microbiology and Immunology
140 Scholarly works
8 Projects
HIGHLIGHTS
2025
Journal article
An integrated multi-omic approach for discovery and dereplication of bioactive microbial natural products
DOI: 10.1099/mgen.0.0015522024
Journal article
Inclusion of TAT and NLS sequences in lipopeptide molecules generates homogenous nanoparticles for gene delivery applications
DOI: 10.1016/j.ijpharm.2024.1244922023
Journal article
Development of Matrix-Embedded Bovine Tracheal Organoids to Study the Innate Immune Response against Bovine Respiratory Disease
DOI: 10.3390/organoids20200072022
Journal article
Abstract 3502: AXA-042 - a novel systemic TLR2/6 agonist for anti-tumor therapy
DOI: 10.1158/1538-7445.am2022-35022022
Conference Proceedings
AXA-042-a novel systemic TLR2/6 agonist for anti-tumor therapy
2021
Journal article
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs
DOI: 10.1172/jci.insight.1402672017
Research Contracts
SCHEDULE 7: INNA-006 Patent Exemplification
RECENT SCHOLARLY WORKS
2021
Journal article
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
DOI: 10.1016/j.ebiom.2020.1031532020
Journal article
Vaccine-specific immune responses against mycobacterium ulcerans infection in a low-dose murine challenge model
DOI: 10.1128/IAI.00753-192020
Journal article
Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use in an out-bred population
DOI: 10.1016/j.vaccine.2019.10.0552019
Journal article
Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune Response
DOI: 10.1021/acs.molpharmaceut.9b00026
RECENT PROJECTS
2015
Research contracts (non-grants)
Lead Selection for Respiratory Program
2013
Research Contracts
Utilization of TLR2 Agonist Pam2Cys as Adjuvant to Facilitate the Development of Staphylococcus Aureus and Respiratory Syncytial Virus Subunit Vaccines
2013
Internal Research Grant
A New Vaccine to Prevent Diarrhoea Caused by Enterotoxigenic E. Coli (Etec)
2009
Research Grant
Is Pam2Cys the New Anti-Viral Against Influenza a Virus?